KRTAP5-14P

Across TCGA pan-cancer cohorts, KRTAP5-14P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated KRTAP5-14P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher KRTAP5-14P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRTAP5-14P expression acts as an unfavorable survival marker.

COAD, LIHC, and TGCT are the cancer types where KRTAP5-14P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	0.035	0.791	<.001	72	view →
LIHC	OS	Tertile	II,III,IV	0.051	0.696	<.001	36	view →
TGCT	DFS	Tertile	All	0.172	0.801	.033	18	view →
UCEC	DFS	Tertile	All	0.159	0.651	.010	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

KRTAP5-14P–COAD (DFS)

Open the COAD breakdown →